Audi, J.; Belson, M.; Patel, M.; Schier, J.; Osterloh, J. (2005). Ricin poisoning: A comprehensive review. J. Am. Med. Assoc. 294, 2342–2351.
Baluna, R.; Vitetta, E.S. (1997). Vascular leak syndrome: A side effect of immunotherapy. Immunopharmacology 37, 117–132.
Becher, F.; Duriez, E.; Volland, H.; Tabet, J.C.; Ezan, E. (2007). Detection of functional ricin by immunoaffinity and liquid chromatography-tandem mass spectrometry. Anal. Chem. 79, 659–665.
Brinkworth, C.S. (2010). Identification of ricin in crude and purified extracts from castor beans using on-target tryptic digestion and MALDI mass spectrometry. Anal. Chem. 82, 5246–5252.
Crompton, R.; Gall, D. (1980). Georgi Markov-death in a pellet. Med. Leg. J. 48, 51–62.
Frankel, A.E.; Woo, J.-H.; Neville, D.M. (2009). Principles of Cancer Biotherapy, 5th ed.; Springer Netherlands: Dodrecht, The Netherlands
Franz, D.R.; Jaax, N.K. (1997). Ricin Toxin. In Medical Aspects of Chemical and Biological Warfare; Sidell, F.R., Takafuji, E.T., Franz, D.R., Eds.; TMM Publications: Washington, DC, USA, 631–642.
Furman, R.R.; Grossbard, M.L.; Johnson, J.L.; Pecora, A.L.; Cassileth, P.A.; Jung, S.-H.; Peterson, B.A.; Nadler, L.M.; Freedman, A.; Bayer, R.-L.; et al. (2011). A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254. Leuk. Lymphoma 52, 587–596.
Griffiths, G.D. (2011). Understanding ricin from a defensive viewpoint. Toxins (Basel) 3, 1373-92.
He, X.; McMahon, S.; Henderson, T.D., II; Griffey, S.M.; Cheng, L.W. (2010). Ricin toxicokinetics and its sensitive detection in mouse sera or feces using immuno-PCR. PLoS One 5, 0012858.
Kalb, S.R.; Barr, J.B. (2009) Mass spectrometric detection of ricin and its activity in food and clinical samples. Anal. Chem. 81, 2037–2042.
Kirby, R. (2004) Ricin toxin: A military history. CML Army Chem. Rev. PB 3–04, 38–40.
Kull, S., Kirchner, S., Pauly, D., Stoermann, B., Dorner, M.B., Lasch, P., Naumann, D., Dorner, B.G. (2010). Multiplex detection of microbial and plant toxins by immunoaffinity enrichment and matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chem. 82, 2916-24.
Moran, G.J. (2002). Threats in bioterrorism. II: CDC category B and C agents. Emerg. Med. Clin. North Am. 20, 311–330. Östin, A.; Bergström, T.; Fredriksson, S.A.; Nilsson, C. (2007). Solvent-assisted trypsin digestion of ricin for forensic identification by LC-ESI MS/MS. Anal. Chem. 79, 6271–6278.
Pauly, D., Kirchner, S., Stoermann, B., Schreiber, T., Kaulfuss, S., Schade, R., Zbinden, R., Avondet, M.A., Dorner, M.B., Dorner, B.G. (2009). Simultaneous quantification of five bacterial and plant toxins from complex matrices using a multiplexed fluorescent magnetic suspension assay. Analyst 134, 2028 – 2039.
Pauly, D., Worbs, S., Kirchner, S., Shatohina, O., Dorner, M.B., Dorner, B.G. (2012). Real-Time Cytotoxicity Assay for Rapid and Sensitive Detection of Ricin from Complex Matrices. PLoS ONE 7 (4): e35360
Poli, M.A.; Rivera, V.R.; Hewetson, J.F.; Merrill, G.A. (1994). Detection of ricin by colorimetric and chemiluminescence ELISA. Toxicon 32, 1371–1377.
Schieltz, D.M.; McGrath, S.C.; McWilliams, L.G.; Rees, J.; Bowen, M.D.; Kools, J.J.; Dauphin, L.A.; Gomez-Saladin, E.; Newton, B.N.; Stang, H.L.; et al. (2011). Analysis of active ricin and castor bean proteins in a ricin preparation, castor bean extract, and surface swabs from a public health investigation. Forensic. Sci. Int. 209, 70–79.
Schindler, J.; Gajavelli, S.; Ravandi, F.; Shen, Y.; Parekh, S.; Braunchweig, I.; Barta, S.; Ghetie, V.; Vitetta, E.; Verma, A. (2011). A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia. Br. J. Haematol., 1–6.
Spitler, L.E.; del Rio, M.; Khentigan, A.; Wedel, N.I.; Brophy, N.A.; Miller, L.L.; Harkonen, W.S.; Rosendorf, L.L.; Lee, H.M.; Mischak, R.P.; et al. (1987). Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Cancer Res. 47, 1717–1723. Strebhardt, K.; Ullrich, A. (2008). Paul Ehrlich’s magic bullet concept: 100 years of progress. Nat. Rev. Cancer 8, 473–480.
Vitetta, E.S.; Thorpe, P.E.; Uhr, J.W. (1993). Immunotoxins: Magic bullets or misguided missiles? Trends Pharmacol. Sci. 14, 148–154.
Worbs, S., Köhler, K., Pauly, D., Avondet, M.A., Schaer, M., Dorner, M.B., Dorner, B.G. (2011). Ricinus communis intoxications in human and veterinary medicine - a summary of real cases. Toxins 3(10):1332-72.
Wu, A.M.; Senter, P.D. (2005). Arming antibodies: Prospects and challenges for immunoconjugates. Nat. Biotechnol. 23, 1137–1146.
Zhou, X.-X.; Ji, F.; Zhao, J.-L.; Cheng, L.-F.; Xu, C.-F. (2010). Anti-cancer activity of anti-p185Her-2 ricin A chain immunotoxin on gastric cancer cells. J. Gastroenterol. Hepatol. 25, 1266–1275.
Zilinskas, R.A. (1997). Iraq’s biological weapons. J. Am. Med. Assoc. 278, 418–424.